Trial Profile
Pharmacokinetic study of bevacizumab in patients with choroidal neovascularization.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Choroidal neovascularisation
- Focus Pharmacokinetics
- 17 Feb 2016 New trial record